Prosthetic heart valves and the COVID ‐19 pandemic era: What should we be concerned about?
ConclusionsAntiviral therapy in patients with COVID ‐19 with prosthetic heart valves might be an issue responsible for an uncontrolled INR. Liver injury may happen in a minority of patients. Bridging in these patients during the antiviral treatment might be required and because of significant INR fluctuations, it might be safer to prescribe antivir al treatment in an inpatient setting.
Source: Journal of Cardiac Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Negar Omidi,
Seyed Khalil Forouzannia,
Hamidreza Poorhosseini,
Seyed Hossein Ahmadi Tafti,
Shahrzad Salehbeigi,
Masoumeh Lotfi ‐Tokaldany Tags: ORIGINAL ARTICLE Source Type: research
More News: Bleeding | Cardiology | Cardiovascular & Thoracic Surgery | Coronavirus | Coumadin | COVID-19 | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Iran Health | Kaletra | Liver | Middle East Health | Norvir | Oseltamivir | Pandemics | Pneumonia | Tamiflu | Urology & Nephrology | Warfarin